BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21621533)

  • 1. Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase.
    Harada K; Hiramoto-Yamaki N; Negishi M; Katoh H
    Exp Cell Res; 2011 Jul; 317(12):1701-13. PubMed ID: 21621533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphB6 promotes anoikis by modulating EphA2 signaling.
    Akada M; Harada K; Negishi M; Katoh H
    Cell Signal; 2014 Dec; 26(12):2879-84. PubMed ID: 25239188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism.
    Hiramoto-Yamaki N; Takeuchi S; Ueda S; Harada K; Fujimoto S; Negishi M; Katoh H
    J Cell Biol; 2010 Aug; 190(3):461-77. PubMed ID: 20679435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoG regulates anoikis through a phosphatidylinositol 3-kinase-dependent mechanism.
    Yamaki N; Negishi M; Katoh H
    Exp Cell Res; 2007 Aug; 313(13):2821-32. PubMed ID: 17570359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ephexin4-mediated promotion of cell migration and anoikis resistance is regulated by serine 897 phosphorylation of EphA2.
    Kawai H; Kobayashi M; Hiramoto-Yamaki N; Harada K; Negishi M; Katoh H
    FEBS Open Bio; 2013; 3():78-82. PubMed ID: 23772378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.
    Fang WB; Ireton RC; Zhuang G; Takahashi T; Reynolds A; Chen J
    J Cell Sci; 2008 Feb; 121(Pt 3):358-68. PubMed ID: 18198190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity.
    Kaibori Y; Saito Y; Nakayama Y
    FASEB J; 2019 Apr; 33(4):5334-5349. PubMed ID: 30668924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermolecular steric inhibition of Ephexin4 is relieved by Elmo1.
    Kim K; Lee J; Lee SA; Moon H; Park B; Kim D; Joo YE; Park D
    Sci Rep; 2017 Jun; 7(1):4404. PubMed ID: 28667327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Rac1 by RhoG regulates cell migration.
    Katoh H; Hiramoto K; Negishi M
    J Cell Sci; 2006 Jan; 119(Pt 1):56-65. PubMed ID: 16339170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand binding up-regulates EphA2 messenger RNA through the mitogen-activated protein/extracellular signal-regulated kinase pathway.
    Pratt RL; Kinch MS
    Mol Cancer Res; 2003 Dec; 1(14):1070-6. PubMed ID: 14707290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
    Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H
    Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation.
    Díaz-Montero CM; Wygant JN; McIntyre BW
    Eur J Cancer; 2006 Jul; 42(10):1491-500. PubMed ID: 16759849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
    Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
    Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.
    Fang WB; Brantley-Sieders DM; Parker MA; Reith AD; Chen J
    Oncogene; 2005 Nov; 24(53):7859-68. PubMed ID: 16103880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkA overexpression enhances growth and metastasis of breast cancer cells.
    Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
    Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
    Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD
    Breast Cancer Res Treat; 2011 Jun; 127(2):375-84. PubMed ID: 20602165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conditional feedback loop regulates Ras activity through EphA2.
    Macrae M; Neve RM; Rodriguez-Viciana P; Haqq C; Yeh J; Chen C; Gray JW; McCormick F
    Cancer Cell; 2005 Aug; 8(2):111-8. PubMed ID: 16098464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
    Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
    Cell Death Differ; 2009 Apr; 16(4):571-83. PubMed ID: 19079138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous RhoG is rapidly activated after epidermal growth factor stimulation through multiple guanine-nucleotide exchange factors.
    Samson T; Welch C; Monaghan-Benson E; Hahn KM; Burridge K
    Mol Biol Cell; 2010 May; 21(9):1629-42. PubMed ID: 20237158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF-induced serine 897 phosphorylation of EphA2 regulates epithelial morphogenesis of MDCK cells in 3D culture.
    Harada K; Negishi M; Katoh H
    J Cell Sci; 2015 May; 128(10):1912-21. PubMed ID: 25908849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.